Promis Neurosciences Stock Analysis

ProMIS Stock Analysis Notes

About 45.0% of the company outstanding shares are owned by corporate insiders. The book value of ProMIS Neurosciences was at this time reported as 0.2. The company had not issued any dividends in recent years. ProMIS Neurosciences had 1:60 split on the 28th of June 2022. ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimers disease , amyotrophic lateral sclerosis , and multiple system atrophy in Canada. ProMIS Neurosciences, Inc. was incorporated in 2004 and is headquartered in Toronto, Canada. Promis Neurosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 5 people. To find out more about ProMIS Neurosciences contact the company at 416 847 6898 or learn more at https://www.promisneurosciences.com.

ProMIS Neurosciences Investment Alerts

ProMIS Neurosciences Upcoming and Recent Events

ProMIS Largest EPS Surprises

View All Earnings Estimates

ProMIS Stock Institutional Investors

Note, although ProMIS Neurosciences' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

ProMIS Market Capitalization

The company currently falls under 'Micro-Cap' category with a total capitalization of 30.73 M.

ProMIS Profitablity

Management Efficiency

ProMIS Neurosciences has Return on Asset of (4.8073) % which means that on every $100 spent on assets, it lost $4.8073. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (10.9851) %, meaning that it generated no profit with money invested by stockholders. ProMIS Neurosciences' management efficiency ratios could be used to measure how well ProMIS Neurosciences manages its routine affairs as well as how well it operates its assets and liabilities. As of the 3rd of December 2024, Return On Tangible Assets is likely to drop to -1.02. In addition to that, Return On Capital Employed is likely to drop to -3.51. At this time, ProMIS Neurosciences' Total Assets are very stable compared to the past year. As of the 3rd of December 2024, Other Assets is likely to grow to 1.21, while Non Current Assets Total are likely to drop about 24.5 K.

Technical Drivers

As of the 3rd of December, ProMIS Neurosciences holds the Variance of 21.68, coefficient of variation of (1,074), and Risk Adjusted Performance of (0.06). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of ProMIS Neurosciences, as well as the relationship between them.

ProMIS Neurosciences Price Movement Analysis

ProMIS Neurosciences Insider Trading Activities

ProMIS Neurosciences Predictive Daily Indicators

ProMIS Neurosciences Forecast Models

ProMIS Neurosciences' time-series forecasting models are one of many ProMIS Neurosciences' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary ProMIS Neurosciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how ProMIS Neurosciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling ProMIS shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as ProMIS Neurosciences. By using and applying ProMIS Stock analysis, traders can create a robust methodology for identifying ProMIS entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. ProMIS analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. ProMIS analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

ProMIS Neurosciences stock analysis indicators help investors evaluate how ProMIS Neurosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading ProMIS Neurosciences shares will generate the highest return on investment. By understating and applying ProMIS Neurosciences stock analysis, traders can identify ProMIS Neurosciences position entry and exit signals to maximize returns.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ProMIS Neurosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. To learn how to invest in ProMIS Stock, please use our How to Invest in ProMIS Neurosciences guide.You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ProMIS Neurosciences. If investors know ProMIS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ProMIS Neurosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of ProMIS Neurosciences is measured differently than its book value, which is the value of ProMIS that is recorded on the company's balance sheet. Investors also form their own opinion of ProMIS Neurosciences' value that differs from its market value or its book value, called intrinsic value, which is ProMIS Neurosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ProMIS Neurosciences' market value can be influenced by many factors that don't directly affect ProMIS Neurosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between ProMIS Neurosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if ProMIS Neurosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ProMIS Neurosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.